HOLLY MILLER: Open Payments
NPI 1609286749 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,192 in 58 payments from 16 companies in 2025. Trend: 2023 $1,956 · 2024 $2,180 · 2025 $1,192
Food & beverage: $1,017Education: $175
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $358 |
| Janssen Biotech, Inc. | 9 | $139 |
| Novartis Pharmaceuticals Corporation | 6 | $132 |
| Incyte Corporation | 4 | $121 |
| Arcutis Biotherapeutics, Inc. | 6 | $98 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $90 |
| Botanix SB Inc | 3 | $58 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| UCB, Inc. | 1 | $25 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $24 |
Products named: RINVOQ, TREMFYA, COSENTYX, OPZELURA, Zoryve, SKYRIZI, SOFDRA, DUPIXENT.
Industry payments across CA — which companies pay providers there.
